Literature DB >> 33086849

Therapy of uveal melanoma A Review.

Š Rusňák, L Hecová, Z Kasl, M Sobotová, L Hauer.   

Abstract

The aim of intraocular melanoma therapy is to achieve local tumor control, reduce the risk of metastasis development, preserve the eyeball and possibly the visual function of the eye. The choice of therapeutic approach requires a comprehensive view and individual approach to each patient with uveal melanoma. Factors considered include local finding (location, tumor size and shape, tumor activity, central visual acuity, intraocular complications), age and the patients overall physical and psychological condition, as well as the patients wishes. The most widely used method of uveal melanoma treatment is radiotherapy. The effect of radiation is caused by the absorption of ionizing radiation energy, the effect of radiation on the cell is manifested by cell death (depletion), or by a cytogenetic information change (mutation). Brachytherapy uses scleral applicators with radionuclide - ruthenium (Ru-106) applicators dominate in Europe and iodine (I-125) applicators in the USA. In external radiotherapy, the source of ionizing radiation is outside the patients body. Both stereotactic radiosurgery and fractionated stereotactic radiotherapy are used. In the Czech Republic, treatment is carried out using Leksell gamma knife or CyberKnife, while proton therapy dominates in the world. The development of serious radiation complications (radiation retinopathy, neuropathy, neovascular glaucoma, toxic tumor syndrome, etc.) should be considered. Surgical therapy involves a variety of invasive procedures. Iridectomy is performed for iris melanoma. Anteriorly located choroidal melanomas and / or ciliary body melanomas can be resolved by transscleral resection (exoresection). For posterior choroidal melanomas, a combination of external tumor irradiation with pars plana vitrectomy is used. Enucleation is a method of choice in advanced tumors that cannot be effectively irradiated. Orbital exenteration is indicated in advanced tumors with extrabulbar spread or in relapsed tumor after previous enucleation.

Entities:  

Keywords:  brachytherapy; endoressection; exoressection; radiotherapy; teleradiotherapy; uveal melanoma

Mesh:

Substances:

Year:  2020        PMID: 33086849     DOI: 10.31348/2020/10

Source DB:  PubMed          Journal:  Cesk Slov Oftalmol        ISSN: 1211-9059


  4 in total

1.  Histopathologic and MR Imaging Appearance of Spontaneous and Radiation-Induced Necrosis in Uveal Melanomas: Initial Results.

Authors:  Pietro Valerio Foti; Corrado Inì; Giuseppe Broggi; Renato Farina; Stefano Palmucci; Corrado Spatola; Rocco Luca Emanuele Liardo; Roberto Milazzotto; Luigi Raffaele; Vincenzo Salamone; Rosario Caltabiano; Lidia Puzzo; Andrea Russo; Michele Reibaldi; Antonio Longo; Paolo Vigneri; Massimo Venturini; Francesco Giurazza; Teresio Avitabile; Antonio Basile
Journal:  Cancers (Basel)       Date:  2022-01-02       Impact factor: 6.639

2.  A Necroptosis-Related Prognostic Model of Uveal Melanoma Was Constructed by Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases.

Authors:  Jiaheng Xie; Liang Chen; Qikai Tang; Wei Wei; Yuan Cao; Chuyan Wu; Jing Hang; Kai Zhang; Jingping Shi; Ming Wang
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

Review 3.  Importance of Optical Coherence Tomography and Optical Coherence Tomography Angiography in the Imaging and Differentiation of Choroidal Melanoma: A Review.

Authors:  Iwona Obuchowska; Joanna Konopińska
Journal:  Cancers (Basel)       Date:  2022-07-10       Impact factor: 6.575

4.  Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma.

Authors:  Feng Zhang; Yan Deng; Dong Wang; Shuai Wang
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.